Re-treatment of previous non-responders and relapsers to interferon plus ribavirin with peginterferon alfa-2a (40KD), ribavirin ± amantadine in patients with chronic hepatitis C: randomized multicentre clinical trial
Mario G. Pessôa
, Hugo Cheinquer†, Paulo R.L. Almeida‡, Giovanni F. Silva§, Maria Patelli J.S. Lima||, Raymundo Paraná**, Marco A. Lacerda††, Edison R. Parise‡‡, José R.B. Pernambuco§§, Suelene S. Pedrosa¶¶, Rosângela Teixeira***, Hoel Sette Jr†††, Fernando Tatsch‡‡‡
,
Corresponding author
* University of Sao Paulo School of Medicine and Instituto de Infectologia Emilio Ribas, Sao Paulo, Brazil
† Federal University of Rio Grande do Sul, Porto Alegre, Brazil
‡ Federal University of Health Sciences of Porto Alegre, Porto Alegre, Brazil
§ State University of Botucatu, Botucatu, Brazil
|| PUC Campinas, Campinas, Brazil
** Federal University of Bahia, Salvador, Brazil
†† Indiana University, Indiana, USA
‡‡ Federal University of Sao Paulo, Sao Paulo, Brazil
§§ Federal University of Pernambuco, Recife, Brazil
¶¶ Santa Casa de Misericòrdia de Goiânia, Goiânia, Brazil
*** Federal University of Minas Gerais, Belo Horizonte, Brazil
††† Hospital Alemao Oswaldo Cruz, Sao Paulo, Brazil
‡‡‡ Roche Produtos Quimicos e Farmacéuticos, Sao Paulo, Brazil
Ver másRead
1968
Timeswas read the article
526
Total PDF
1442
Total HTML
| Year/Month | Html | Total | |
|---|---|---|---|
| 2025 12 | 24 | 6 | 30 |
| 2025 11 | 113 | 62 | 175 |
| 2025 10 | 38 | 27 | 65 |
| 2025 9 | 21 | 10 | 31 |
| 2025 8 | 20 | 30 | 50 |
| 2025 7 | 45 | 46 | 91 |
| 2025 6 | 39 | 15 | 54 |
| 2025 5 | 16 | 2 | 18 |
| 2025 4 | 22 | 3 | 25 |
| 2025 3 | 55 | 2 | 57 |
| 2025 2 | 47 | 4 | 51 |
| 2025 1 | 43 | 3 | 46 |
| 2024 12 | 28 | 2 | 30 |
| 2024 11 | 16 | 1 | 17 |
| 2024 10 | 13 | 5 | 18 |
| 2024 9 | 5 | 7 | 12 |
| 2024 8 | 16 | 9 | 25 |
| 2024 7 | 23 | 0 | 23 |
| 2024 6 | 22 | 4 | 26 |
| 2024 5 | 19 | 3 | 22 |
| 2024 4 | 45 | 5 | 50 |
| 2024 3 | 26 | 3 | 29 |
| 2024 2 | 26 | 5 | 31 |
| 2024 1 | 8 | 6 | 14 |
| 2023 12 | 5 | 6 | 11 |
| 2023 11 | 5 | 3 | 8 |
| 2023 10 | 9 | 4 | 13 |
| 2023 9 | 12 | 3 | 15 |
| 2023 8 | 16 | 2 | 18 |
| 2023 7 | 12 | 3 | 15 |
| 2023 6 | 15 | 3 | 18 |
| 2023 5 | 48 | 5 | 53 |
| 2023 4 | 43 | 2 | 45 |
| 2023 3 | 31 | 1 | 32 |
| 2023 2 | 22 | 5 | 27 |
| 2023 1 | 15 | 9 | 24 |
| 2022 12 | 18 | 8 | 26 |
| 2022 11 | 20 | 7 | 27 |
| 2022 10 | 6 | 7 | 13 |
| 2022 9 | 9 | 5 | 14 |
| 2022 8 | 3 | 5 | 8 |
| 2022 7 | 13 | 5 | 18 |
| 2022 6 | 7 | 6 | 13 |
| 2022 5 | 9 | 5 | 14 |
| 2022 4 | 11 | 6 | 17 |
| 2022 3 | 9 | 5 | 14 |
| 2022 2 | 20 | 3 | 23 |
| 2022 1 | 52 | 6 | 58 |
| 2021 12 | 34 | 6 | 40 |
| 2021 11 | 21 | 6 | 27 |
| 2021 10 | 40 | 11 | 51 |
| 2021 9 | 37 | 8 | 45 |
| 2021 8 | 11 | 4 | 15 |
| 2021 7 | 5 | 6 | 11 |
| 2021 6 | 10 | 8 | 18 |
| 2021 5 | 12 | 7 | 19 |
| 2021 4 | 21 | 13 | 34 |
| 2021 3 | 18 | 5 | 23 |
| 2021 2 | 4 | 7 | 11 |
| 2021 1 | 7 | 7 | 14 |
| 2020 12 | 10 | 5 | 15 |
| 2020 11 | 8 | 9 | 17 |
| 2020 10 | 9 | 5 | 14 |
| 2020 9 | 11 | 4 | 15 |
| 2020 8 | 4 | 2 | 6 |
| 2020 7 | 4 | 0 | 4 |
| 2020 6 | 3 | 3 | 6 |
| 2020 5 | 5 | 5 | 10 |
| 2020 4 | 4 | 3 | 7 |
| 2020 3 | 4 | 2 | 6 |
| 2020 2 | 2 | 3 | 5 |
| 2020 1 | 2 | 3 | 5 |
| 2019 12 | 5 | 6 | 11 |
| 2019 11 | 6 | 3 | 9 |
| 2019 10 | 0 | 1 | 1 |
| 2019 9 | 1 | 3 | 4 |
| 2019 8 | 1 | 1 | 2 |
| 2019 7 | 2 | 2 | 4 |
| 2019 6 | 1 | 4 | 5 |
Show all
